Home/Pipeline/Expandable Interbody Portfolio

Expandable Interbody Portfolio

Spinal Fusion

Iterative DevelopmentActive

Key Facts

Indication

Spinal Fusion

Phase

Iterative Development

Status

Active

Company

Globus Medical

About Globus Medical

Globus Medical's mission is to move with urgency to deliver innovations that improve the quality of life for patients with musculoskeletal disorders. Its core strategy is the integration of proprietary implants with advanced enabling technologies like the Excelsius robotic navigation ecosystem to enhance surgical precision, safety, and efficiency. The company's landmark 2023 merger of equals with NuVasive created a global spine powerhouse, significantly scaling its product portfolio, R&D capabilities, and commercial reach to drive sustainable growth in the $10B+ global spine market.

View full company profile

Therapeutic Areas

Spine Disorders Orthopedic Disorders Limb Reconstruction

Other Spinal Fusion Drugs

Drug	Company	Phase	Status
Mimetic Metal Technology Development	CoreLink Surgical	Development/Commercial	Active
Bone Graft Substitute	BiologicsMD	Pre-clinical	Active
VisuALIF	SpineSmith	Commercial	Active
ASTRO Registry	Artoss	Post-Market	Active
Hive Smart Implant Exploration	NanoHive Medical	Pre-clinical R&D	Active
ProLift Pivot Expandable Spacer System	Life Spine	FDA Cleared	Active
NEXXT MATRIXX Clinical Evidence Study	Nexxt Spine	Post-Market Study	Active
AGA111	Angitia Biopharmaceuticals	Phase 3	Active
X-PAC® Portfolio Expansion	Expanding Innovations	Development	Active
SOLACE™	Xenix Medical	Commercial	Active
TrellOss Porous Ti Interbody System	HighRidge Medical	Approved	Active
Nano FortiCore Interbody System	Nanovis	Commercial	Active